Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy.

Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy. Med Oncol. 2014 Jul; 31(7):45.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.